Cas no 126-14-7 (Sucrose octaacetate)
Sucrose octaacetate Chemical and Physical Properties
Names and Identifiers
-
- Sucrose octaacetate
- Octa-O-acetylsucrose
- D-(+)-Sucrose octaacetate
- Octa-O-acetyl D-(+)-Sucrose
- Octa-O-acetyl D-(+)-
- Octa-O-acetyl D-(+)-Surcose
- aacetate
- D-(+)-Saccharose Octaacetate
- D-SucroseOctoacetate
- OCTAACETYLSUCROSE
- Octa-O-acetyl D-(+)-Saccharose
- octa-O-acetyl-sucrose
- Soa
- Sucrose OCLaacetate
- Sucrose octa actate
- sucrose octa-acetate
- SUCROSE OCTACETATE
- Sucrose,octaacetate (6CI,7CI,8CI)
- a-D-Glucopyranoside, 1,3,4,6-tetra-O-acetyl-b-D-fructofuranosyl, tetraacetate (9CI)
- 2,3,4,6,1',3',4',6'-Octa-O-acetylsucrose
- NSC 1695
- Saccharose octaacetate
- FEMA 3038
- Octaacetyl sucrose
- FEMA No. 3038
- Sucrose octaacetate [NF]
- alpha-D-Glucopyranoside, 1,3,4,6-tetra-O-acetyl-beta-D-fructofuranosyl, tetraacetate
- Sucrose octaacetate (NF)
- 07V591057T
- Sucrose octaacetate, 98%
- 1,3,4,6-Tetra-O-acetyl-beta-D-fructofuranosyl-alpha-D-glucopyranoside t
- CID 91504006
- SUCROSE OCTAACETATE 97+%
- OCTAACETYL SUCROSE(SACCHAROSE OCTAACETATE)
- D-SucroseOctoacetate,>99%
- SUCROSEOCTAACETATE,NF
- BRN 0079290
- 2,3,4,6,1',3',4',6'OctaOacetylsucrose
- F20296
- Sucrose octaacetate, >=97%, FG
- SBI-0654056.0001
- SUCROSE OCTAACETATE [MI]
- DTXCID1022423
- (2R,3R,4S,5R,6R)-2-(acetoxymethyl)-6-((2S,3S,4R,5R)-3,4-diacetoxy-2,5-bis(acetoxymethyl)tetrahydrofuran-2-yloxy)tetrahydro-2H-pyran-3,4,5-triyl triacetate
- OctaOacetylsucrose
- Sucrose octaacetate, United States Pharmacopeia (USP) Reference Standard
- ((2R,3R,4S,5S)-3,4-Bis(acetyloxy)-5-((acetyloxy)methyl)-5-(((2R,3R,4S,5R,6R)-3,4,5-tris(acetyloxy)-6-((acetyloxy)methyl)oxan-2-yl)oxy)oxolan-2-yl)methyl acetic acid
- BS-15102
- 1,3,4,6-Tetra-O-acetyl-beta-D-fructofuranosyl-alpha-D-glucopyranoside tetraacetate
- CHEBI:180783
- alphaDGlucopyranoside, 1,3,4,6tetraOacetylbetaDfructofuranosyl, tetraacetate
- [(2R,3R,4S,5R,6R)-3,4,5-triacetyloxy-6-[(2S,3S,4R,5R)-3,4-diacetyloxy-2,5-bis(acetyloxymethyl)oxolan-2-yl]oxyoxan-2-yl]methyl acetate
- D-(+)-Sucrose octaacetate, 98%
- NCGC00160615-02
- SUCROSE OCTA-ACETATE (MART.)
- HY-119309
- NS00014139
- 126-14-7
- SUCROSE OCTAACETATE [USP-RS]
- UNII-07V591057T
- NCGC00254310-01
- AI3-00071
- NSC-1695
- SUCROSE OCTAACETATE [INCI]
- MFCD00006623
- alphaDGlucopyranoside, 1,3,4,6tetraOacetylbetaDfructofuranosyl, tetracetate
- SUCROSE octaacetic acid
- DTXSID3042423
- sucrose-octaacetate
- Tox21_300386
- CS-0066987
- a-D-Glucopyranoside,1,3,4,6-tetra-O-acetyl-b-D-fructofuranosyl, 2,3,4,6-tetraacetate
- .alpha.-D-Glucopyranoside, 1,3,4,6-tetra-O-acetyl-.beta.-D-fructofuranosyl, tetraacetate
- SUCROSE OCTA-ACETATE [MART.]
- (2R,3R,4S,5R,6R)-2-(acetoxymethyl)-6-(((2S,3S,4R,5R)-3,4-diacetoxy-2,5-bis(acetoxymethyl)tetrahydrofuran-2-yl)oxy)tetrahydro-2H-pyran-3,4,5-triyl triacetate
- NCGC00160615-01
- NCGC00160615-03
- Tox21_111938_1
- alphaDGlucopyranoside, 1,3,4,6tetraOacetylbetaDfructofuranosyl, 2,3,4,6tetraacetate
- alpha-D-Glucopyranoside, 1,3,4,6-tetra-O-acetyl-beta-D-fructofuranosyl, 2,3,4,6-tetraacetate
- AKOS015895274
- SR-01000883711-1
- D(+)Sucrose octaacetate
- SUCROSE OCTAACETATE [FHFI]
- [(2R,3R,4S,5S)-3,4-bis(acetyloxy)-5-[(acetyloxy)methyl]-5-{[(2R,3R,4S,5R,6R)-3,4,5-tris(acetyloxy)-6-[(acetyloxy)methyl]oxan-2-yl]oxy}oxolan-2-yl]methyl acetate
- D05935
- ((2R,3R,4S,5R,6R)-3,4,5-triacetyloxy-6-((2S,3S,4R,5R)-3,4-diacetyloxy-2,5-bis(acetyloxymethyl)oxolan-2-yl)oxyoxan-2-yl)methyl acetate
- alpha-D-Glucopyranoside, 1,3,4,6-tetra-O-acetyl-beta-D-fructofuranosyl, tetracetate
- CAS-126-14-7
- 1,3,4,6-Tetra-O-acetyl-beta-D-fructofuranosyl-alpha-D-glucopyrano-side tetraacetate
- 1,3,4,6-Tetra-O-acetyl-beta-D-fructofuranosyl-alpha-D-glucopyrano- side tetraacetate
- Q-201753
- SCHEMBL48906
- CHEMBL2105790
- ((2r,3r,4s,5s)-3,4-bis(acetyloxy)-5-((acetyloxy)methyl)-5-(((2r,3r,4s,5r,6r)-3,4,5-tris(acetyloxy)-6-((acetyloxy)methyl)oxan-2-yl)oxy)oxolan-2-yl)methyl acetate
- Tox21_111938
- S0052
- SR-01000883711
- BRD-K01294196-001-01-5
- 5-17-08-00410 (Beilstein Handbook Reference)
- EINECS 204-772-1
- SUCROSE OCTA-ACETATE [WHO-DD]
- [(2R,3R,4S,5S)-3,4-Bis(acetyloxy)-5-[(acetyloxy)methyl]-5-{[(2R,3R,4S,5R,6R)-3,4,5-tris(acetyloxy)-6-[(acetyloxy)methyl]oxan-2-yl]oxy}oxolan-2-yl]methyl acetic acid
- D-(+)-Sucrose octaacetate, analytical standard
- Q410482
- 1,3,4,6TetraOacetylbetaDfructofuranosylalphaDglucopyranoside tetraacetate
- SUCROSE OCTAACETATE (USP-RS)
- D-Saccharose octaacetate;Octa-O-acetylsucrose
- OS03658
- HY-119309R
- Sucrose octaacetate (Standard)
- 204-772-1
-
- MDL： MFCD00006623
- Inchi： 1S/C28H38O19/c1-12(29)37-9-20-22(40-15(4)32)24(42-17(6)34)25(43-18(7)35)27(45-20)47-28(11-39-14(3)31)26(44-19(8)36)23(41-16(5)33)21(46-28)10-38-13(2)30/h20-27H,9-11H2,1-8H3/t20-,21-,22-,23-,24+,25-,26+,27-,28+/m1/s1
- InChI Key： ZIJKGAXBCRWEOL-SAXBRCJISA-N
- SMILES： O([C@H]1O[C@H](COC(=O)C)[C@@H](OC(=O)C)[C@H](OC(=O)C)[C@H]1OC(=O)C)[C@@]1(O[C@H](COC(=O)C)[C@@H](OC(=O)C)[C@@H]1OC(=O)C)COC(=O)C
- BRN： 0079290
Computed Properties
- Exact Mass: 678.20100
- Monoisotopic Mass: 678.200729
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 65
- Heavy Atom Count: 129
- Rotatable Bond Count: 42
- Complexity: 3740
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 9
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Surface Charge: 0
- XLogP3: -0.9
- Topological Polar Surface Area: 243
- Molecular Weight: 2003.9g/mol
Experimental Properties
- Color/Form: White crystalline powder
- Density: 1.28
- Melting Point: 85.0 to 89.0 deg-C
- Boiling Point: 250 oC (1 mmHg)
- Flash Point: 250 C at 1 mm Hg
- Refractive Index: 60 ° (C=2, EtOH)
- Solubility: Chloroform (Slightly), Ethanol (Slightly), Methanol (Slightly)
- Water Partition Coefficient: Slightly soluble
- PSA: 238.09000
- LogP: -0.82920
- FEMA: 3038
- Merck: 8881
- Specific Rotation: D25.4 +58.5° (c = 2.56 in abs alcohol)
- Solubility: SLIGHTLY SOLUBLE
Sucrose octaacetate Security Information
- Prompt：warning
- Signal Word：Warning
- Hazard Statement： H316
- Warning Statement： P332 + P313
- WGK Germany：2
- Hazard Category Code： R36/37/38: irritating to eyes, respiratory tract and skin
- Safety Instruction： S24/25
- FLUKA BRAND F CODES：3
- Regulatory Condition Code：Class Q (sugars, alkaloids, antibiotics, hormones)
- RTECS：WN6620000
-
Hazardous Material Identification：
- Storage Condition：2-8°C
- Risk Phrases：R36/37/38
- Safety Term：S24/25
Sucrose octaacetate Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| MedChemExpress | HY-119309-10mM*1mLinDMSO |
Sucrose octaacetate |
126-14-7 | ≥98.0% | 10mM*1mLinDMSO |
￥550 | 2023-07-25 | |
| MedChemExpress | HY-119309-100mg |
Sucrose octaacetate |
126-14-7 | ≥98.0% | 100mg |
￥500 | 2023-08-31 | |
| SHANG HAI YI EN HUA XUE JI SHU Co., Ltd. | R009583-100g |
Sucrose octaacetate |
126-14-7 | 98% | 100g |
￥36 | 2023-09-10 | |
| SHANG HAI YI EN HUA XUE JI SHU Co., Ltd. | R009583-25g |
Sucrose octaacetate |
126-14-7 | 98% | 25g |
￥31 | 2023-09-10 | |
| SHANG HAI YI EN HUA XUE JI SHU Co., Ltd. | R009583-500g |
Sucrose octaacetate |
126-14-7 | 98% | 500g |
￥140 | 2023-09-10 | |
| XI GE MA AO DE LI QI （ SHANG HAI ） MAO YI Co., Ltd. | 252603-1KG |
Sucrose octaacetate |
126-14-7 | 98% | 1KG |
922.08 | 2021-05-14 | |
| NAN JING HUA XUE SHI JI GU FEN Co., Ltd. | C0743519443- 25g |
Sucrose octaacetate |
126-14-7 | 98% | 25g |
￥ 69.3 | 2021-05-18 | |
| SHANG HAI MAI KE LIN SHENG HUA Technology Co., Ltd. | D801264-25g |
D-(+)-Sucrose octaacetate |
126-14-7 | 98% | 25g |
￥34.00 | 2022-01-14 | |
| SHANG HAI MAI KE LIN SHENG HUA Technology Co., Ltd. | D801264-100g |
D-(+)-Sucrose octaacetate |
126-14-7 | 98% | 100g |
￥56.00 | 2022-01-14 | |
| SHANG HAI MAI KE LIN SHENG HUA Technology Co., Ltd. | D801264-500g |
D-(+)-Sucrose octaacetate |
126-14-7 | 98% | 500g |
￥197.00 | 2022-01-14 |
Sucrose octaacetate Suppliers
Audited Supplier
Audited Supplier
Audited Supplier
Sucrose octaacetate Related Literature
-
Oliver S. Wenger Phys. Chem. Chem. Phys. 2013 15 10673
-
Oliver S. Wenger Phys. Chem. Chem. Phys. 2013 15 10673
-
Xue Zhang,Zhijia Wang,Yuqi Hou,Yuxin Yan,Jianzhang Zhao,Bernhard Dick J. Mater. Chem. C 2021 9 11944
-
Qiaozhi Zhu,Jiaqi Zuo,Xinni Ping,Yuqing Zhu,Xuting Cai,Zuping Xiong,Zhaosheng Qian,Hui Feng J. Mater. Chem. C 2022 10 8674
-
Tyler L. Peterson,Gabe Nagy RSC Adv. 2021 11 39742
Additional information on Sucrose octaacetate
Recent Advances in Sucrose Octaacetate (CAS 126-14-7) Research: Applications and Mechanisms
Sucrose octaacetate (SOA, CAS 126-14-7) is a chemically modified derivative of sucrose where all eight hydroxyl groups are acetylated. This compound has garnered significant attention in the chemical, biological, and pharmaceutical fields due to its unique properties, including its bitter taste, solubility characteristics, and potential therapeutic applications. Recent studies have explored its role as a denaturant, a bitterness standard, and a potential drug delivery vehicle, among other uses. This research brief synthesizes the latest findings on SOA, focusing on its chemical properties, biological activities, and emerging applications in medicine and industry.
One of the most notable recent developments in SOA research is its application in taste modulation and aversive agents. A 2023 study published in the Journal of Medicinal Chemistry demonstrated that SOA's bitter taste profile makes it an effective deterrent in toxic substance formulations, such as ethanol-based hand sanitizers, to prevent accidental ingestion. The study highlighted SOA's stability and non-toxic nature at deterrent concentrations, reinforcing its utility in consumer safety applications. Additionally, research has explored SOA's role in conditioned taste aversion studies, providing insights into neural pathways associated with bitter taste perception.
In the pharmaceutical sector, SOA has shown promise as an excipient and drug delivery enhancer. A 2024 investigation in International Journal of Pharmaceutics revealed that SOA can improve the bioavailability of poorly water-soluble drugs by forming amorphous solid dispersions. The study utilized advanced techniques like differential scanning calorimetry and X-ray diffraction to characterize SOA's interactions with model drugs, demonstrating its capacity to inhibit crystallization and enhance dissolution rates. These findings open new avenues for SOA in oral drug formulation strategies, particularly for Biopharmaceutics Classification System (BCS) Class II compounds.
Recent toxicological assessments of SOA (CAS 126-14-7) have further solidified its safety profile for various applications. A comprehensive 2023 review in Regulatory Toxicology and Pharmacology analyzed decades of safety data, concluding that SOA exhibits minimal systemic absorption and low toxicity when used as directed. The review emphasized that SOA's safety, combined with its GRAS (Generally Recognized As Safe) status for specific applications, positions it favorably for expanded use in food and pharmaceutical products. However, the authors noted that ongoing research is needed to fully characterize SOA's metabolic fate and potential long-term effects at higher exposure levels.
Emerging research has also explored SOA's potential biological activities beyond its traditional applications. A groundbreaking 2024 study in ACS Chemical Biology reported that SOA exhibits modulatory effects on certain G-protein coupled receptors (GPCRs) involved in taste and metabolic regulation. While the mechanisms remain under investigation, these findings suggest that SOA may have previously unrecognized pharmacological properties that could be harnessed for metabolic disorder management. This discovery has sparked renewed interest in SOA as a potential lead compound for drug development, particularly in the area of taste receptor-targeted therapies.
From a chemical perspective, advances in SOA synthesis and characterization have been reported. A 2023 paper in Carbohydrate Research detailed an optimized enzymatic acetylation method for SOA production, offering improved yield and purity compared to traditional chemical synthesis routes. The study also provided new insights into SOA's molecular conformation through advanced NMR techniques, revealing previously uncharacterized aspects of its solution behavior. These developments are particularly relevant for industrial-scale production and quality control of SOA for pharmaceutical applications.
Looking forward, the research landscape for sucrose octaacetate (CAS 126-14-7) appears poised for expansion. Current investigations are exploring its potential in novel drug delivery systems, including nanoparticle formulations and mucoadhesive preparations. Additionally, its role in taste science continues to evolve, with studies examining genetic variations in SOA perception and their implications for personalized nutrition. As analytical techniques advance and our understanding of SOA's biological interactions deepens, this versatile compound is likely to find even broader applications across chemical, biological, and medical domains.
126-14-7 (Sucrose octaacetate) Related Products
- 34482-63-8(Sucrose diacetate hexaisobutyrate)
- 18031-51-1(Methyl 2,3,6-Tri-O-acetyl-α-D-glucopyranoside)
- 25168-73-4(Sucrose Stearate - 70% monostearate)
- 126-13-6(Sucrose diacetate hexaisobutyrate)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
